Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
Charles E. Holjencin, Andrew Jakymiw
Cells (2022) Vol. 11, Iss. 15, pp. 2332-2332
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Current research trends of nanomedicines
Qiuyue Liu, Jiahui Zou, Zhongjian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4391-4416
Open Access | Times Cited: 75
miRNA-Based Technologies in Cancer Therapy
Maria Pagoni, Claudia Cava, Diamantis C. Sideris, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1586-1586
Open Access | Times Cited: 30
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 29
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders
Morgan Minjares, Wendy Wu, Jie‐Mei Wang
Cells (2023) Vol. 12, Iss. 9, pp. 1341-1341
Open Access | Times Cited: 24
The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Nanotechnology for climate change mitigation: Enhancing plant resilience under stress environments
Abbas Shoukat, Britta Pitann, Muhammad Mubashar Zafar, et al.
Journal of Plant Nutrition and Soil Science (2024) Vol. 187, Iss. 5, pp. 604-620
Open Access | Times Cited: 7
Advances in MicroRNA Therapeutics: from Preclinical to Clinical Studies
Simona Brillante, Mariagrazia Volpe, Alessia Indrieri
Human Gene Therapy (2024) Vol. 35, Iss. 17-18, pp. 628-648
Closed Access | Times Cited: 7
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Unraveling the path to osteoarthritis management: targeting chondrocyte apoptosis for therapeutic intervention
Yi Ting Lee, Mohd Heikal Mohd Yunus, Muhammad Dain Yazid, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance
Conner Belnap, Tyler Divis, Karl Kingsley, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2167-2167
Open Access | Times Cited: 4
Recent Advances in SAW Sensors for Detection of Cancer Biomarkers
M. Aleixandre, M.C. Horrillo
Biosensors (2025) Vol. 15, Iss. 2, pp. 88-88
Open Access
Recent Advances in Nanomedicines Loaded with MicroRNAs for Cancer Demethylation Therapy
Qiuyu Tan, Jinxia Wang, Ye Tian, et al.
Precision medicine and engineering. (2025), pp. 100023-100023
Open Access
MicroRNAs in Preeclampsia: Bridging Diagnosis and Treatment
Angeliki Gerede, Sofoklis Stavros, Maria Danavasi, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2003-2003
Open Access
Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines
Kieran Caberto Huni, Jacky Cheung, Madeline Sullivan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1244-1244
Open Access | Times Cited: 11
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
Ganna Aleshcheva, Christian Baumeier, Dominik Harms, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 6, pp. 3410-3418
Open Access | Times Cited: 9
Non-coding RNAs Affect Breast Cancer Development Through the Notch Signaling Pathway: An Overview
Alireza Ahmadi, Amin Moqadami, Mohammad Khalaj‐Kondori, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 44-56
Open Access | Times Cited: 3
The potential of microRNAs in cancer diagnostic and therapeutic strategies: a narrative review
Minh Trong Quang, Minh Nam Nguyen
The Journal of Basic and Applied Zoology (2024) Vol. 85, Iss. 1
Open Access | Times Cited: 3
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration—Where Are We Now?
Mariana Ferreira, Mariana Morais, Rui Medeiros, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1347-1347
Open Access | Times Cited: 3
MicroRNA-mediated epigenetic regulation of inflammasomes in inflammatory responses and immunopathologies
Young‐Su Yi
Seminars in Cell and Developmental Biology (2022) Vol. 154, pp. 227-238
Closed Access | Times Cited: 12
The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
Małgorzata Kozłowska, Agnieszka Śliwińska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10252-10252
Open Access | Times Cited: 7
Non-coding RNAs in gynecologic cancer
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117618-117618
Closed Access | Times Cited: 7
InflammamiRs in focus: Delivery strategies and therapeutic approaches
Yeliz Z. Akkaya‐Ulum, Başak Şen, Tayfun Hilmi Akbaba, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Open Access | Times Cited: 2
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications
Fatemeh Hosseinpour-Soleimani, Zahra Salmasi, Younes Ghasemi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28167-e28167
Open Access | Times Cited: 2
Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression
Abdollah Jafarzadeh, Bahar Naseri, Hossein Khorramdelazad, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top